CTCA Chief Medical Officer and five-year cancer survivor, Dr. Edgar Staren discusses benefits of new therapies and introduces an integrative approach to cancer care in upcoming webinar. ...

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB (lapatinib) as a first- line, all-oral treatment for women with metastatic breast cancer. ...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive. ...

Researchers from Temple University discuss findings in colon cancer NewsRx.com February 11, 2010 According to a study from the United States, Despite evidence of a decline in both incidence and prevalence of colorectal cancer nationwide, it remains the second most commonly...

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

Tumor-host interaction at the invasive front of colorectal cancer represents a critical interface encompassing a dynamic process of de- differentiation of colorectal carcinoma cells known as epithelial mesenchymal transition (EMT). EMT can be identified histologically by the presence of tumor budding, a feature which ...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

ArQule, Inc. announced the initiation of a Phase 2, single agent trial with ARQ 197 in germ cell tumors (GCT), including testicular and non- central nervous system (non-CNS) tumors, and a Phase 1/2 clinical trial designed to evaluate the safety of ARQ 197 administered in ...

Despite improved knowledge regarding the etiology of ovarian cancer, as well as application of aggressive surgery and chemotherapy, there has been only a modest change in the mortality statistics over the last 30 years. Given these results and the evolution of targeted therapies, there...

Use of symptoms to trigger a medical evaluation for ovarian cancer does not appear to detect early-stage ovarian cancer earlier and would likely result in diagnosis in only 1 out of 100 women in the general population with such symptoms, according to an article published...

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

CTCA Chief Medical Officer and five-year cancer survivor, Dr. Edgar Staren discusses benefits of new therapies and introduces an integrative approach to cancer care in upcoming webinar. ...

In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of the Department of Energy laboratory. ...

Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients....

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

CTCA Chief Medical Officer and five-year cancer survivor, Dr. Edgar Staren discusses benefits of new therapies and introduces an integrative approach to cancer care in upcoming webinar. ...

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women's Hospital, the H. Lee Moffitt Cancer Center, Dartmouth's Hitchcock Medical Center and the University...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

CTCA Chief Medical Officer and five-year cancer survivor, Dr. Edgar Staren discusses benefits of new therapies and introduces an integrative approach to cancer care in upcoming webinar. ...

More bad news for soda-drinkers: A University of Minnesota study suggests that drinking two or more soft drinks a week nearly doubles the risk of developing pancreatic cancer. Mark Pereira, an associate professor at the School of Public Health, and his research team studied the...

Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). ...

Although the associations between grilled (broiled) or barbecued meats or fish intake and stomach cancer risk have been investigated, the evidence implicating heterocyclic amine (HCA) intake as a cause of stomach cancer is limited. We conducted a case-control study to investigate the association between...

According to recent research from the United States, Obesity and diabetes are strong risk factors that drive the development of type I endometrial cancers. Recent epidemiological evidence suggests that metformin may lower cancer risk and reduce rates of cancer deaths among diabetic patients. ...

As cancer survivors live longer, questions arise about what kind of care long-term survivors require. A recently published study from Case Western Reserve University's Mandel School of Applied Social Sciences found 245 older married women who survived cancer had more health problems as compared...

Sociologists at Case Western Reserve University found that when passive cancer patients become survivors, they have plenty of bold advice to offer other cancer patients, according to a study in JAGS, the Journal of American Geriatric Society. ...

My birthday is on the 11th, my mom's is on the 12th, my brother's is on the 13th and my father's is on the 14th -- all in different months. Since my dad's birthday is in February, my Valentine's Day reflections are for him.At M. D. Anderson we're always focused...

Scientists at M. D. Anderson and Rice have proposed a solution to an imaging challenge that arises when a moving target is imaged using a combined PET/CT scanner. The CT portion of the scanner takes a quick, three-dimensional snapshot of the tumor's anatomical location. The PET scan takes a few...

When I started volunteering at M. D. Anderson, I would often wonder at the end of a busy work day if I had enough energy to fight the Houston traffic and make my rounds visiting inpatients as a volunteer floor host. What I discovered was that I often left the...

Dr. Elizabeth Blackburn, 2009 Nobel Laureate, is the "real deal." She's an outstanding scientist, a role model for women in science, a wife, a mother, a fascinating person and the ultimate mentor. ...

VIDEO - Patients from the Children's Cancer Hospital at M. D. Anderson Cancer Center kicked off the 2010 Valentine season with a special Valentine-making party ...

Naghma Ahmed, Senior Physical Therapist at M. D. Anderson's Rehabilitation Services, discusses what can be done to help cancer patients recover from physical conditions caused by cancer treatments, including:  general deconditioning, frozen shoulder, tendentious, peripheral neuropathies, and radiation fibrosis.... ...

Eric Chang, M.D., Associate Professor in the Department of Radiation Oncology at M. D. Anderson Cancer Center, discusses the gamma knife radiosurgery technology. This treatment uses gamma rays, a form of high-energy radiation, that focus on a very small area... ...

Lorenzo Cohen, Ph.D., director, and Kay Garcia, LAc, Dr.P.H., clinical nurse specialist, both in M. D. Anderson's Integrative Medicine discuss how acupuncture can be used to help relieve some of the side effects accompanying cancer treatment.... ...

Chris Holsinger, M.D., surgeon in the Head and Neck Department at M. D. Anderson Cancer Center, is the first to perform the transaxillary robotic thyroidectomy (operation using a robotic device for thyroid surgery) in the United States. He explains how... ...

Michelle C. Fingeret, Ph.D., Assistant Professor in the Department of Behavioral Science with joint appointments in the Departments of Plastic Surgery and Head and Neck Surgery at the University of Texas M. D. Anderson Cancer Center discusses her innovative line... ...

Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to treatment or recurs later, when cure is much less likely. Quicker identification of non-responding tumors appears to be possible using a new mathematical model developed by...

A newly released study concludes that people tend to match their risk perceptions about policy issues with their cultural values, which may explain the intense disagreement about proposals to vaccinate elementary-school girls against human-papillomavirus (HPV). The study also says people's values shape their perceptions of...

A test for the two strains of human papillomavirus responsible for most cervical cancers is under study. The molecular assay uses a cervical scraping, like that for a liquid-based Pap smear, to test for HPV types 16 and 18, responsible for 70 percent of cervical...

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women observed that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. The study, conducted by University of Illinois...

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia. The vaccine, called nine-valent, is being compared with Gardasil, a quadrivalent vaccine already on the market that works against the two most deadly...

Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, as per a research studyconducted at...

With a novel therapeutic delivery system, a research team led by researchers at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovary cancer cells. Using the EphA2 protein as a molecular homing mechanism, chemotherapy was...

A team of scientists led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to therapy with usually used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10...

Recurrent and metastatic endometrial and ovary cancers can be notoriously difficult to treat: They have spread to other organs and typically have developed resistance to chemotherapy; and patients already heavily treated with chemotherapy may not be able to endure more chemo. Now, physicians at Albert...

Recurrent low-grade serous carcinoma, a rare type of ovary cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovary cancers, as per scientists from The University of Texas M. D. Anderson Cancer Center. The findings were reported at...